Showing results (1691-1700 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|December 3, 2020
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
European Journal of Heart Failure|October 28, 2020
A current and future outlook on upcoming technologies in remote monitoring of patients with heart failureTarek Bekfani, Marat Fudim, John G F Cleland, et al.
European Journal of Heart Failure|October 28, 2020
Measuring physical activity with activity monitors in patients with heart failure: from literature to practice. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of CardiologyLeonie Klompstra, Martha Kyriakou, Ekaterini Lambrinou, et al.
European Journal of Heart Failure|September 10, 2022
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trialMichael Böhm, Javed Butler, Felix Mahfoud, et al.
European Journal of Heart Failure|September 8, 2022
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of CardiologyAntoni Bayes-Genis, Alberto Aimo, Pardeep Jhund, et al.
European Journal of Heart Failure|September 26, 2022
Health-related quality of life in acute heart failure: association between patient-reported symptoms and markers of congestionMatthew M Y Lee, Ross T Campbell, Brian L Claggett, et al.
European Journal of Heart Failure|March 17, 2021
Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaireAlice Ravera, Bernadet T Santema, Iziah E Sama, et al.
European Journal of Heart Failure|November 12, 2021
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HFJawad H Butt, Kieran F Docherty, Pardeep S Jhund, et al.
European Journal of Heart Failure|March 20, 2021
Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failureEva M Boorsma, Jozine M Ter Maaten, Kevin Damman, et al.
Pageof 398